4 free views remaining today

mandibulofacial dysostosis, Guion-Almeida type

Description

Mandibulofacial Dysostosis, Guion-Almeida Type (MFDGA) is a rare genetic syndrome characterized by progressive microcephaly, midface and malar hypoplasia, micrognathia, microtia, and other craniofacial abnormalities [1][3][5].

Key Features:

  • Progressive microcephaly: The head circumference decreases over time [1]
  • Midface and malar hypoplasia: Underdevelopment of the midface and cheekbones [2][4]
  • Micrognathia: A small lower jaw [1][5]
  • Microtia: Abnormalities of the ears, including small or absent ears [1][3]
  • Craniofacial dysmorphisms: Other facial abnormalities, such as a flat face, short nose, and abnormal eye shape [7]

Causes and Inheritance: MFDGA is an autosomal dominant disorder, meaning that a single copy of the mutated gene is enough to cause the condition. It is inherited in an autosomal dominant pattern, which means that each child of an affected parent has a 50% chance of inheriting the mutated gene [6].

References:

[1] Context result 5 [2] Context result 4 [3] Context result 3 [4] Context result 8 [5] Context result 5 [6] Context result 6 [7] Context result 7

Additional Characteristics

  • Micrognathia
  • Microcephaly
  • Microtia
  • Craniofacial dysmorphisms
  • Midface and malar hypoplasia

Signs and Symptoms

Common Features of Mandibulofacial Dysostosis (MFD) and Guion-Almeida Syndrome

Individuals with Mandibulofacial Dysostosis, also known as Guion-Almeida syndrome, may exhibit a range of physical and developmental characteristics. Some common signs and symptoms include:

  • Developmental Delays: Affected individuals often experience delays in development, ranging from mild to severe intellectual disability [1].
  • Craniofacial Abnormalities: Malar hypoplasia (underdeveloped cheekbones), micrognathia (small jaw), oblique palpebral fissures (eyes slanted upwards), and microtia (small ears) are common features [2, 3].
  • Speech and Language Problems: Individuals with MFD may experience difficulties with speech and language development [1].
  • Heart Problems: Heart issues can occur in some individuals with this disorder [4].
  • Short Stature: Short stature is another feature that can be present in people with MFD [4, 5].
  • Hearing Loss: Conductive hearing loss often requires the use of hearing aids or hearing processor devices [5].

Additional Features

Less common features associated with Mandibulofacial Dysostosis include:

  • Cleft Palate: A cleft palate can occur in some individuals with this disorder.
  • Deep Philtrum: A deep philtrum (groove between the nose and upper lip) may be present.
  • Downslanted Palpebral Fissures: Eyes that are slanted downwards can also be a feature.

References

[1] Context 1: Affected individuals have developmental delay and intellectual disability that can range from mild to severe. Speech and language problems are ... [2] Context 2: Other common features included malar hypoplasia, micrognathia, oblique palpebral fissures, and microtia, usually resulting in conductive hearing loss. [3] Context 3: Clinical features · Anteverted nares · Choanal atresia · Cleft palate · Deep philtrum · Downslanted palpebral fissures · Epicanthus · Midface retrusion · Short nose. [4] Context 1: Heart problems, abnormalities of the thumbs, and short stature are other features that can occur in MFDM. Some people with this disorder also ... [5] Context 5: Eating and speech difficulties. Hearing loss often requiring hearing aids or hearing processor devices. Less common: heart issues, short stature, malformations ...

Additional Symptoms

  • Hearing Loss
  • Developmental Delays
  • Cleft Palate
  • Craniofacial Abnormalities
  • Speech and Language Problems
  • Heart Problems
  • Deep Philtrum
  • Downslanted Palpebral Fissures
  • short stature

Diagnostic Tests

Diagnostic Tests for Mandibulofacial Dysostosis, Guion-Almeida Type

Mandibulofacial dysostosis, Guion-Almeida type (MFDGA) is a rare genetic disorder that requires accurate diagnosis to ensure proper management and care. The following diagnostic tests are commonly used to diagnose MFDGA:

  • Genetic analysis: This test involves analyzing the EFTUD2 gene for mutations or variations that can cause MFDGA. Exome-based NextGen sequencing with CNV analysis is a recommended testing approach [8][9].
  • Prenatal testing and preimplantation genetic testing: These tests are used to detect MFDGA in unborn babies or embryos, respectively. Molecular genetic testing can be performed once the EFTUD2 pathogenic variant has been identified in an affected family member [4].
  • Clinical evaluation: A consultation and evaluation with a clinical genetic specialist is essential to determine if someone has a diagnosis of MFDGA. Specialists may also suggest specific genetic testing or other types of tests to help reach a diagnosis [12].

Key Points

  • Genetic analysis, particularly exome-based NextGen sequencing with CNV analysis, is a recommended diagnostic test for MFDGA.
  • Prenatal testing and preimplantation genetic testing can be used to detect MFDGA in unborn babies or embryos.
  • A clinical evaluation by a specialist is necessary to determine if someone has a diagnosis of MFDGA.

References

[4] Prenatal Testing and Preimplantation Genetic Testing. Molecular genetic testing. Once the EFTUD2 pathogenic variant has been identified in an affected family member, this test can be performed. [8] Our favored testing approach is exome-based NextGen sequencing with CNV analysis. [9] Specialists may also suggest specific genetic testing or other types of tests to help reach a diagnosis. [12] To find out if someone has a diagnosis of Mandibulofacial Dysostosis, Guion-Almeida Type (MFDGA), it is important to have a consultation and evaluation with a clinical genetic specialist.

Additional Diagnostic Tests

  • Clinical evaluation
  • Prenatal testing and preimplantation genetic testing
  • Genetic analysis

Treatment

Treatment Overview

Mandibulofacial dysostosis, Guion-Almeida type (MFDM) is a rare genetic disorder that requires a multidisciplinary approach to treatment. While there is no cure for MFDM, various treatments can help manage its symptoms and improve quality of life.

Drug Treatment

According to the search results, treatment for MFDM focuses on correcting facial structures and improving function [5]. However, specific drug treatment options are not explicitly mentioned in the provided context.

Alternative Therapies

While there is no direct mention of drug treatment, some alternative therapies may be considered as part of a comprehensive treatment plan. These can include:

  • Craniofacial surgery to enlarge the airway and correct facial structures [5]
  • Occupational, physical, and speech therapies to address developmental delays and intellectual disabilities [2]

Genetic Considerations

MFDM is an autosomal dominant disorder, which means that individuals with a family history of the condition may be more likely to develop it. Genetic counseling may be recommended for families affected by MFDM.

Rare Disease Information

The Integrated disease information for Mandibulofacial Dysostosis, Guion-Almeida Type [6] provides a comprehensive overview of the disorder, including associated genes, mutations, phenotypes, pathways, and drugs. However, specific drug treatment options are not explicitly mentioned in this resource either.

Conclusion

While there is no direct mention of specific drug treatments for MFDM, various alternative therapies may be considered as part of a comprehensive treatment plan. It is essential to consult with a multidisciplinary team of healthcare professionals to determine the best course of treatment for individuals affected by this rare genetic disorder.

Citations:

  • [5] - Treatment is focused on function and correcting facial structures.
  • [2] - Occupational, physical, and speech therapies ...
  • [6] - Integrated disease information for Mandibulofacial Dysostosis, Guion-Almeida Type

Recommended Medications

  • Craniofacial surgery to enlarge the airway and correct facial structures
  • Occupational, physical, and speech therapies to address developmental delays and intellectual disabilities

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Mandibulofacial Dysostosis, Guion-Almeida Type

Mandibulofacial dysostosis, Guion-Almeida type (MFDM) is a rare genetic syndrome characterized by progressive microcephaly, midface and malar hypoplasia, micrognathia, microtia, and other craniofacial anomalies. When considering the differential diagnosis for MFDM, several conditions should be taken into account.

Conditions to Consider:

  • Treacher Collins Syndrome: This condition is characterized by mandibular hypoplasia, micrognathia, and other craniofacial abnormalities. It often presents with similar symptoms to MFDM.
  • Nager Syndrome: A rare genetic disorder that affects the development of the face and ears, leading to characteristic facial features and hearing loss.
  • CHARGE Syndrome: A complex condition involving multiple congenital anomalies, including craniofacial dysmorphia, heart defects, and hearing impairment.
  • Oculo-Auriculo-Vertebral Spectrum (OAVS): A rare genetic disorder that affects the development of the eyes, ears, and spine, leading to characteristic facial features and other anomalies.

Key Features to Consider:

When differentiating MFDM from these conditions, it is essential to consider the following key features:

  • Microcephaly: Progressive microcephaly is a hallmark feature of MFDM.
  • Midface and malar hypoplasia: The presence of midface and malar hypoplasia can help distinguish MFDM from other craniofacial anomalies.
  • Micrognathia and microtia: These features are often present in MFDM, but may also be seen in Treacher Collins Syndrome and Nager Syndrome.

References:

  • [1] Mandibulofacial dysostosis with microcephaly (MFDM) is an extremely rare genetic syndrome characterised by microcephaly, external ear abnormalities, and other craniofacial anomalies. [7]
  • These syndromes should all be considered in the differential diagnosis when prenatal features of craniofacial anomalies, including micrognathia, are encountered. [9]

Note: The above answer is based on the information provided in the search results within the context block.

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080196
core#notation
DOID:0080196
oboInOwl#hasDbXref
ORDO:79113
IAO_0000115
A syndrome characterized by progressive microcephaly, micrognathia, microtia, dysplastic ears, preauricular skin tags, speech delay, significant developmental delay, midface and malar hypoplasia.
oboInOwl#hasExactSynonym
MFDM syndrome
rdf-schema#label
mandibulofacial dysostosis, Guion-Almeida type
rdf-schema#subClassOf
t353860
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2567
owl#annotatedSource
t353910

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.